Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06459583 · ClinicalTrials.gov registry record · NA
Evaluation of Self-Mediated Alternatives for Risk Testing Education and Return of Results
A NA study, sponsored by Banner Health.
- Completed
- Registry status
- NA
- Development phase
- 681
- Enrollment target
NCT06459583 is a NA study that has completed, run by Banner Health. The registered enrollment target is 681 participants.
The verdict
NCT06459583, a NA study, has completed, sponsored by Banner Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 681 participants
- Enrollment target
Study Summary
This randomized non-inferiority study will evaluate self-directed scalable electronic health platform (eHealth) methods for communicating Alzheimer's gene and biomarker results compared to videoconference telehealth disclosure with healthcare providers, as well as characterize the impacts of learning this information on the participant.
Interventions
- OTHER eHealth Platform
- OTHER Videoconference Telehealth Platform
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 681 participants |
| Start Date | 2024-10-10 |
| Est. Completion | 2025-11-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06459583
The ClinicalTrials.gov registry entry for NCT06459583 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 681 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Banner Health, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which eHealth Platform is the first listed.
NCT06459583 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06459583 about?
NCT06459583 is a clinical study titled "Evaluation of Self-Mediated Alternatives for Risk Testing Education and Return of Results". This randomized non-inferiority study will evaluate self-directed scalable electronic health platform (eHealth) methods for communicating Alzheimer's gene and biomarker results compared to videoconference telehealth disclosure with healthcare providers, as well as characterize the impacts of learnin...
What is the current status of trial NCT06459583?
This trial is currently completed. It is a NA study. The enrollment target is 681 participants. The study started on 2024-10-10. Estimated completion is 2025-11-07.
What interventions are being tested in trial NCT06459583?
The interventions under investigation include: eHealth Platform (OTHER), Videoconference Telehealth Platform (OTHER).
Who is sponsoring clinical trial NCT06459583?
This trial is sponsored by Banner Health, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.